Literature DB >> 3229452

EEG changes in untreated hyperthyroidism and under the conditions of thyreostatic treatment.

H J Leubuscher1, F Herrmann, K Hambsch, D Langpeter, P Mueller, D Sorger.   

Abstract

20 patients with hyperthyroidism were observed with repeated EEG measurements before and during treatment (ObsidanR; MethimazolR). 17 patients, before starting antithyroid therapy, had slight to moderate EEG abnormalities. A prevalence for moderate disturbances occurred for patients with a higher degree of hyperthyroidism. The dominant EEG frequency was higher than in euthyroid controls, but no exact correlation to T3-values could be observed. 16 patients showed abnormal reactivity to photic stimulation. One-week therapy by propranolol produced only a slight synchronizing effect in EEG's, where T3-values decreased. After 4 weeks selective therapy by MethimazolR all patients were euthyroid, but some EEG abnormalities persisted in 12 patients in a lower degree. The dominant EEG frequency decreased to control-group ranges and abnormal photic reactivity was reduced. After 6 months some EEG disturbances re-increased tentiatively, in 3 relapses excessively. These observations confirm the prognostic value of EEG measurements for the recognition of occurrence and persistence of cerebral disturbances in severe metabolic dysfunctions.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3229452     DOI: 10.1055/s-0029-1210785

Source DB:  PubMed          Journal:  Exp Clin Endocrinol        ISSN: 0232-7384


  2 in total

Review 1.  Electroencephalography of encephalopathy in patients with endocrine and metabolic disorders.

Authors:  Roland Faigle; Raoul Sutter; Peter W Kaplan
Journal:  J Clin Neurophysiol       Date:  2013-10       Impact factor: 2.177

2.  Bitemporal independent 3-Hz spike-and-waves in adult patient with idiopathic generalized epilepsy and Graves disease.

Authors:  Amayak Broutian; Snezhana Dolgova; Alexandra Belyakova-Bodina; Anna Abramova; Anastasia Lukianova; Tatiana Noskova
Journal:  Clin Neurophysiol Pract       Date:  2020-10-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.